Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital
Descripción del Articulo
Objectives: To determine the diagnostic performance of fine needle aspiration biopsy (FNAB) for diagnosing malignant thyroid nodules. Methods: This is a retrospective study that assessed thyroid FNABs in Guillermo Almenara-Irigoyen National Hospital in Lima, Peru, during a three-year period. Cytopat...
Autores: | , , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2024 |
Institución: | Colegio Médico del Perú |
Repositorio: | Acta Médica Peruana |
Lenguaje: | español |
OAI Identifier: | oai:ojs.pkp.sfu.ca:article/2882 |
Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/2882 |
Nivel de acceso: | acceso abierto |
Materia: | Biopsy, Fine-Needle Thyroid Nodule Thyroid Neoplasms Cytology Neoplasm Staging |
id |
REVCMP_3375f68d5a551b6d9d37748d38176e2d |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/2882 |
network_acronym_str |
REVCMP |
network_name_str |
Acta Médica Peruana |
repository_id_str |
. |
dc.title.none.fl_str_mv |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital Utilidad diagnóstica de citopatología para diagnóstico de nódulos tiroideos malignos en un hospital peruano |
title |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
spellingShingle |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital Luna-Victorio, Laura Biopsy, Fine-Needle Thyroid Nodule Thyroid Neoplasms Cytology Neoplasm Staging |
title_short |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
title_full |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
title_fullStr |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
title_full_unstemmed |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
title_sort |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospital |
dc.creator.none.fl_str_mv |
Luna-Victorio, Laura Gamarra Chevarría, María Fabiola Velazco Cabrejos, Sandra Margarita Ildefonso Najarro, Sofía Pilar Plasencia Dueñas, Esteban Failoc-Rojas, Virgilio E |
author |
Luna-Victorio, Laura |
author_facet |
Luna-Victorio, Laura Gamarra Chevarría, María Fabiola Velazco Cabrejos, Sandra Margarita Ildefonso Najarro, Sofía Pilar Plasencia Dueñas, Esteban Failoc-Rojas, Virgilio E |
author_role |
author |
author2 |
Gamarra Chevarría, María Fabiola Velazco Cabrejos, Sandra Margarita Ildefonso Najarro, Sofía Pilar Plasencia Dueñas, Esteban Failoc-Rojas, Virgilio E |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
Biopsy, Fine-Needle Thyroid Nodule Thyroid Neoplasms Cytology Neoplasm Staging |
topic |
Biopsy, Fine-Needle Thyroid Nodule Thyroid Neoplasms Cytology Neoplasm Staging |
description |
Objectives: To determine the diagnostic performance of fine needle aspiration biopsy (FNAB) for diagnosing malignant thyroid nodules. Methods: This is a retrospective study that assessed thyroid FNABs in Guillermo Almenara-Irigoyen National Hospital in Lima, Peru, during a three-year period. Cytopathologic diagnosis of biopsies was categorized using the Bethesda System, considering categories V and VI as malignant, and category II as benign. A single biopsy per patient was obtained, and results with the highest value in the Bethesda System were considered. All patients underwent thyroidectomy and histopathological results were characterized as malignant or benign. Results: One hundred and seventy-three patients were included in the study. Their cytopathology results were Bethesda II to VI. Cytological diagnosis showed that 47.4% of all patients were Bethesda VI. Nearly sixty percent (59.5%) of thyroid nodules were malignant in histopathology, and papillary carcinoma was the most frequent neoplasm. Diagnostic performance of FNAB was high when considering Bethesda V and VI as malignant, with 91.92% sensitivity, 71.67% specificity, 84.26 positive predictive value, 84.31% negative predictive value, and 84.28% precision. Positive verisimilitude rate was 3.39; but this significantly improved when only Bethesda VI was considered as malignant, with 90.7% sensitivity, 89.58% specificity, 90.3% precision, and 8.71 positive verisimilitude rate. Conclusion: FNAB showed good performance. This study proved to be quite useful in our healthcare facility for detecting errors and promote improvement, as well as a model for future research in different healthcare instances. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03-30 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2882 10.35663/amp.2024.411.2882 |
url |
https://amp.cmp.org.pe/index.php/AMP/article/view/2882 |
identifier_str_mv |
10.35663/amp.2024.411.2882 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2882/1605 https://amp.cmp.org.pe/index.php/AMP/article/view/2882/1611 https://amp.cmp.org.pe/index.php/AMP/article/view/2882/1614 |
dc.rights.none.fl_str_mv |
Copyright (c) 2024 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2024 ACTA MEDICA PERUANA |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/html text/xml |
dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
publisher.none.fl_str_mv |
Colegio Médico del Perú |
dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol 41 No 1 (2024): January - March ACTA MEDICA PERUANA; Vol. 41 Núm. 1 (2024): Enero - Marzo 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
instname_str |
Colegio Médico del Perú |
instacron_str |
CMP |
institution |
CMP |
reponame_str |
Acta Médica Peruana |
collection |
Acta Médica Peruana |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1816075113351610368 |
spelling |
Diagnostic utility of cytopathology for the diagnosis of malignant thyroid nodules in a Peruvian hospitalUtilidad diagnóstica de citopatología para diagnóstico de nódulos tiroideos malignos en un hospital peruanoLuna-Victorio, LauraGamarra Chevarría, María FabiolaVelazco Cabrejos, Sandra MargaritaIldefonso Najarro, Sofía PilarPlasencia Dueñas, EstebanFailoc-Rojas, Virgilio EBiopsy, Fine-NeedleThyroid NoduleThyroid NeoplasmsCytologyNeoplasm StagingObjectives: To determine the diagnostic performance of fine needle aspiration biopsy (FNAB) for diagnosing malignant thyroid nodules. Methods: This is a retrospective study that assessed thyroid FNABs in Guillermo Almenara-Irigoyen National Hospital in Lima, Peru, during a three-year period. Cytopathologic diagnosis of biopsies was categorized using the Bethesda System, considering categories V and VI as malignant, and category II as benign. A single biopsy per patient was obtained, and results with the highest value in the Bethesda System were considered. All patients underwent thyroidectomy and histopathological results were characterized as malignant or benign. Results: One hundred and seventy-three patients were included in the study. Their cytopathology results were Bethesda II to VI. Cytological diagnosis showed that 47.4% of all patients were Bethesda VI. Nearly sixty percent (59.5%) of thyroid nodules were malignant in histopathology, and papillary carcinoma was the most frequent neoplasm. Diagnostic performance of FNAB was high when considering Bethesda V and VI as malignant, with 91.92% sensitivity, 71.67% specificity, 84.26 positive predictive value, 84.31% negative predictive value, and 84.28% precision. Positive verisimilitude rate was 3.39; but this significantly improved when only Bethesda VI was considered as malignant, with 90.7% sensitivity, 89.58% specificity, 90.3% precision, and 8.71 positive verisimilitude rate. Conclusion: FNAB showed good performance. This study proved to be quite useful in our healthcare facility for detecting errors and promote improvement, as well as a model for future research in different healthcare instances.Objetivos: determinar el rendimiento diagnóstico de la biopsia por punción aspiración con aguja fina (PAAF) para el diagnóstico de nódulos tiroideos malignos. Materiales y métodos: estudio retrospectivo que evaluó las PAAF de tiroides realizadas en el Hospital Nacional Guillermo Almenara Irigoyen en Lima, Perú, durante un período de tres años. Se categorizó el diagnóstico citopatológico de las biopsias usando el sistema de Bethesda, se consideró las categorías V y VI como malignas y la categoría II como benigna. Se obtuvo solo una biopsia por paciente y se consideró el resultado con la categoría de Bethesda más alta. Todos los pacientes fueron sometidos a tiroidectomía y los resultados histopatológicos se categorizaron como malignos o benignos. Resultados: se incluyó a 173 pacientes con resultados citopatológicos de Bethesda II al VI. El diagnóstico citológico mostró que el 47,4% de los pacientes tenían Bethesda VI. El 59,5% de los nódulos tiroideos fueron malignos en la histopatología, siendo el carcinoma papilar el tipo más frecuente. El rendimiento diagnóstico de la PAAF fue alta cuando considera Bethesda V y VI como malignos, con una sensibilidad 91,92%, especificidad 71,67%, valor predictivo positivo 84,26%, valor predictivo negativo 84,31% y precisión de 84,28%, razón de verosimilitud positiva 3,39; pero mejoró significativamente cuando se consideró solo Bethesda VI como maligno, con sensibilidad del 90,7%, especificidad del 89,58%, precisión 90,3% y razón de verosimilitud positiva 8,71. Conclusiones: la PAAF tiene buen rendimiento. Este estudio demostró ser de gran utilidad en nuestro centro de salud para detectar errores y promover mejoras, así también como modelo para próximas investigaciones en diferentes establecimientos de salud.Colegio Médico del Perú2024-03-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/288210.35663/amp.2024.411.2882ACTA MEDICA PERUANA; Vol 41 No 1 (2024): January - MarchACTA MEDICA PERUANA; Vol. 41 Núm. 1 (2024): Enero - Marzo1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2882/1605https://amp.cmp.org.pe/index.php/AMP/article/view/2882/1611https://amp.cmp.org.pe/index.php/AMP/article/view/2882/1614Copyright (c) 2024 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/28822024-11-17T07:47:37Z |
score |
13.952411 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).